https://www.selleckchem.com/pr....oducts/mptp-hydrochl
Interventions resulted in improvement of care delivery across some elements of care. Overall, we observed a 26% reduction in the T1DCI after 12 months of utilization. CONCLUSIONS The T1DCI is a powerful metric to evaluate the ability of our diabetes program to standardize, quantify, and monitor delivery of optimal diabetes care to children with T1D, and to drive our program toward zero missed opportunities for quality care delivery. © 2020 John Wiley Sons A/S. Published by John Wiley Sons Ltd.PURPOSE Buprenorphine
Like
Comment
Share
